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Summary
There is an increasing interest in measuring human plasma histamine levels in various
clinical conditions. A variety of 'old' and newly developed techniques are applied to
meet this demand. However, the discrepancy between reported reference values for
histamine in human plasma measured using this variety of techniques, suggests the
existence of a certain degree of inaccuracy and imprecision. We therefore organized an
external quality control study on the reliability of current histamine determinations in
European laboratories. Three lyophilized plasma quality control samples, in duplicate,
covering the normal and pathological range of histamine concentrations {0-45 nmol/l),
two different aqueous histamine standard samples and one solvent sample were sent to
10 laboratories for the analysis of their histamine content. The following methods were
used: gas chromatography-mass spectrometry (« = 2), enzymatic single isotopic assay
(«= 1), fiuorometric-fluoroenzymatic assay (« = 3). radioimmunoassay (« = 3) and high
performance liquid chromatography {n = 2). The study was performed and evaluated
according to the approved recommendations (1983) ofthe International Federation of
Clinical Chemistry (IFCC). The target values ±s.d. ofthe three plasma samples were:
39-5±4-6 nmol/l (CV=ll-6%), 2 3 + 2-2 nmo!/l (CV-96%) and 8-9+1-5 nmol/l
(CV=17%), respectively. The target values +s.d. ofthe two aqueous samples were:
0-9± 1-1 nmol/l (CV= 120%; true value: 0 00 nmol/l) and 10 2±0-5nmol/l(CV=5 3%;
true value: 10 Onmol/l), respectively. A Youden plot oftwo unrelated plasma samples in
the pathological range defined 7/11 results as accurate and precise. The Youden plot of
the two unrelated aqueous samples only defined 6/11 results as accurate and precise. In
general, estimating histamine concentrations within the normal range seemed to be the
most difficult part of measuring histamine in human plasma samples. It is suggested to
define reference standards, methods and laboratories for plasma histamine determina-
tions.
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Introduction
Several assays have been developed, varying from bio-
assay, fluorometry. enzymatic assay, chromatography to
radioimmunoassay [1 43] (Table I), for studying endoge-
nous histamine release in man. The determination of
Correspondence: Dr n. Neugebauer, Biochemical and Experimental
Division, llnd Department of Surgery, University of Cologne, Ostmer-
heimer Strasse 200, 5000 Cologne 91, FRG.
histamine concentrations in plasnia has important appli-
cations [14,20,21.27,30.43 54]; because of the short half-
life time of histamine (c. 2 min.) [55, 56] this is especially
important in the field of controlled studies, in which it is
possible to collect blood samples at regular times. How-
ever, in a meta-analysis evaluation about the role of
histamine as a mediator in septic/endotoxic shock, three-
quarters of the relevant studies are quoted as being an
unreliable assay for measuring histamine in human
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Table I. A review of reported reference values of histamine in human plasma (nmol/l).
Literature from 1970 to 1989 was screened by means of computer search, tising the
keywords: 'hislamine", 'analysis" and 'plasma'
Technique and reference Reference no.
Bioassay
Barsoum and Smirk. 1936
Anrep el al... 1944
Adamf(fl/., 1957
Fluorometry
Noah and Brand. 1961
Beall, 1963
Thompson and Walton, 1964
Garden, 1966
Graham cf a/.. 1968
Lorenzc? al,. 1972
Lorenz and Doenickc, 1978
Schoning ff <i/,, 1982
Rehn et ai, 1987
Enzymatic single isotopic assay
Bruce fro/., 1976
Slevenson et al.. 1976
Subramaniaii ('/«/,, 1978
ShafTand Beaven. 1979
Bruce ei al., 1979
Almeida el at., 1980
Brown eta!.. 1980
Moss etal., 1981
Barnes and Brown. 1981
Guilloux el al., 1981
Dyer eiaL. 1982
Verburg Cf«/.. 1983
Haimart ff a/., 1985
Raulsff a/., 1986
Asadcra/., 1987
Haryima ei al., 1988
Enzymatic double isotopic assay
Miller ef a/., 1970
Barnes pf a/,, 1982
Ind era!.. 1983
[11
[21
[3J
[4J
[5]
[6]
[7]
[8]
PI
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[181
[191
[20]
[21]
[22]
[23J
124]
m
P71
[281
[29]
[30]
[31]
High perrormancc liquid chromatography
Tsurutd el al., 1978
Yamatodani el al., 1985
Harsingff a/,, 1986
Arakawa and Tachibana, 1986
Scheinman et al.. 1988
Czerwonka er ul.. 1988
Asskali and Forster. 1989
[32]
[33]
[34]
[35]
[36J
[38]
Gas chromatography-mass spectrometry
Milac/a/. . 1980
Kcyzev et al.. 1984
Payne ei al.. 1989
[39]
[40]
KU
n*
21
7
5
12
15
16
47
62
54
40
299
12
29
10
50
19
25
8
17
6
6
50
51
8
18
3
30
35
11
26
31
10
20
88
5
6
10
5
25
3
Mean ±s.d.
(t±s.c.m.)
54-1
54-1
<9-0
27-0
54-1
72-1
45 0
5-6±2'7
62±2'3
27
3'2
M±0-7
4-0 ±3-4
<2 3
2 0
5'4±09t
5-4±0'9
54±0-9
34 + 0-7
9-7 ±6-0
34±0-6
6-9 + 5-5
2-9±l 5
2-7±07
3-9± l7
l-9±0'2
l-9±0-2t
6-5±4-3
5-4 ±1-8
2-4±0-2t
l-9±0-2t
5-5± l4
4-0+1-6
7-2±2-6
8-1+4-5
0 0
2-4±2-3
3-4±M
7-5 + 3-3
2-1 ±0-8
0-9 + 0-2
Range
27-0-108-1
18-0-99-1
<90-10-8
9-0-81 i
27-0-90-1
36-0-54-1
09-126
0-9-12-6
0-0 8-1
0-0-8-2
0 5-19
0-0-10-8
I 8-l2'6
0-8-4-7
0-0-7-8
1-9-4-3
1-7-2-1
0-9-4-5
0-2-21 0
36-9-0
1-3 15-9
0-0 3-6
4-1 12-9
0 8 3-6
0-8-1-2
Radioimmunassay
McBride er al., 1988 [42] 40 [7 + 0-7 0-8-5-0
* « = number of subjects. The overall mean ± s.d. of the means that were published in
the periods 1960 1969, 1970-1979 and 1980-1989 were 40-8±25-5 (/i = 5;
CV = 63%), 4-6±l-5 (/J = 8; CV = 33%) and 3-8±2-5 nmol/l (« = 25; CV
respectively. See also [47,56],
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plasma and the authors conclude 'it is irrational to
develop theories about any pathomechanism of histamine
release before this error has been carefully excluded" [51].
Also the discrepancy between recently reported reference
values for histamine in human plasma (Table 1: 1980-
1989; n = 25: CV = 67%) suggests that besides possible
sample collection problems [40] and biorhythmic differ-
ences [12], inaccuracy and imprecision may exist, leading
to unreliable reports. This thought has been confirmed in
1980 by Gleich and Hull [57], who published a study in
which 22 laboratories participated, and four different
techniques for the measurement of histamine in plasma
and buffered aqueous solutions containing known
amounts of histamine were evaluated: enzymatic double
isotopic assay, enzymatic single isotopic assay, auto-
mated fluorometric and manual fluorometric assay.
There were several methodological pitfalls in the study
of Gleich and Hull [57]. The variation in reported
reference values, the increasing interest in measuring
histamine, the improvements of'old' techniques and the
development of new chromatographic and immunologi-
cal methods inspired us to organize a renewed external
quality control study on histamine measurement in
plasma in European laboratories, covering five different
techniques: gas chromatography-mass spectrometry
(GCMS), enzymatic double isotopic assay (EDIA). fluor-
ometric fluoroenzymatic assay (FFEA), radioimmu-
noassay (RIA) and high performance liquid chromato-
graphy (HPLC). For each technique two laboratories
were selected.
This study was performed and evaluated according to
the approved recommendations of the International
Federation of Clinical Chemistry (IFCC), dealing on
external quality-control studies in clinical chemistry [58].
Our aims were to establish the ability of several
laboratories using different techniques to obtain the same
results in the same specimens, to provide an overall
measure of inaccuracy and imprecision and to act as an
educational stimulus to improve the performances by
informing the laboratories about their results and to
compare them with those of the other participating
laboratories.
The results of this study were partly presented at the
Munich Consensus Development Conference on Hista-
mine Determination, December 3-7, 1988 [59,60] and at
the 18th Meeting ofthe European Histamine Research
Society, May 17-20, 1989, The Netherlands [61].
Materials and methods
Materials
Reagents. Histamine dihydrochloride (extra pure) was
purchased from Merck, Darmstadt, FRG; water (Baker
Table 2. The participating laboratories with the reported
reference(s) of their method
Result Technique Reference
1 Gas chromatography-mass spectrometry [40,48]
2 Gas chromatography-mass spectrometry [40]
3 Enzymatic single Isolopic assay [15]
4 Fiuorometric-fluoroenzymatic assay [9]
5 Fluoromctric-fluoroenzymatic assay [9]
6 Fluorometric-fluoroenzymalic assay [9]
7 Radioimmunoassay [63]
8 Radioimmunoassay [63]
9 Radioimmunoassay [63]
10 High performance liquid chromalography [64]
11 High performance liquid chromatography [38]
analysed HPLC® reagent) from JT Baker. Devcnter. The
Netherlands; and hydrochloric acid 30% (Suprapur®)
from Merck, Darmstadt, FRG.
Histamine stock solution. Histamine dihydrochloride was
dried at 80 C for one night and cooled at room tempera-
ture in a desiccator for 5 hr. A portion was dried to a
constant weight of 57 49 mg in a desiccator and dissolved
in 250 ml of 01 mol/l hydrochloric acid. Exactly 1 ml of
this solution was diluted further with 01 mol/l hydro-
chloric acid to 250 ml, resulting in a histamine stock
solution containing 4 996 /tmol/1 histamine. This hista-
mine stock solution was used to prepare aqueous and
plasma histamine quality control samples.
Stability control. During the preparatory phase (see
Methods) the effect of lyophilizing plasma samples and
subsequent storage for 4 weeks at -1-4 C on their histamine
concentration was studied by comparison with the hista-
mine concentration obtained in the same plasma samples
without lyophilization and storage for only a few days at
— 20°C. Twelve 5 ml portions of plasma containing three
different amounts of histamine. between 0 and 60 nmol/I,
were prepared by adding different amounts of a histamine
stock solution to pooled human plasma (four portions of
each concentration: Ia-d, Ila-d. Ill a-d). Six portions
(two of each concentration: la, b, Ila, b and llla, b) were
dispensed into 17-ml glass ampules and lyophilized
overnight and sealed with butyl-rubber torches. After 4
weeks storage at -I-4'C, the content ofthe ampules was
redissolved with water and the histamine concentration
determined. The six remaining portions (two of each
concentration: l e d , lie, d and 11 lc,d) were dispensed into
polypropylene tubes, stored at — 2O'C and analysed
within the same week of preparation. All samples were
analysed by GCMS [40,48].
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(a)
90-;
45-
23.30
Target value ± s,d. = 39.5 ± d.6 nmol/1
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Fig. 1, Individual results on quality control plasma samples I (a). II (b) and III (c) atid quality control aqueous samples IV (d)
and V (e).
Plasma hi.ftamine preparation. Blood was collected frotn
13 volutiteers, usitig no medication at all (one female and
12 males, age 22-57 yr), by venepuncture in dry EDTA-
containing evacuated blood collection tubes of 10 ml
(Venoject®, Terumo, Belgium). From the nine blood
samples/volunteer the first one was always discarded. The
samples were immediately cooled in melting ice {0-4"C)
and plasma was prepared within 30 min after blood
collection by centrifugation in a cooled centrifuge {-f- 4'C)
at 1000 Xj(f for 10 min. Using polypropylene pipettes the
plasma was transferred to polypropylene tubes and
centrifuged again for 10 min at 3000 xg in a cooled
centrifuge {-|-4^C). The supernatants were pooled in a
polypropylene container to give a final volume of
approximate 360 ml. After gentle mixing this plasma pool
was subdivided in three equal pools (I-III) in polypropy-
lene containers and cooled.
Ptasma histatnine quality conlrol mniptes. Three different
quality control samples were prepared. Quality control
sample I was prepared by adding I ml (4')96 nmol
histamine) and quality control sample 111 by adding 200
/il (0-999 nmoi histamine) of the histamine stock solution
to plasma pool I and III. respectively. Quality control
sample II consisted of plasma portion II without added
histamine. Exactly 5-g portions (4-9979 + 0 0050; mean
+ s.d.) of the quality control samples I. II and III were
dispensed into 17 ml glass ampules and coded. The
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Fig. 2. Youden plots, (a) of quality control plasma samples I (x')
and III {}•') and (b) of quality control aqueous samples IV (.v')
and V (}•').
plasma samples were lyophilized overnight and sealed
with a butyl-rubber torch. At the time of analysis the
participants were asked to redissolve the contents into
5 ml distilled water (HPLC quality. Baker), to mix for
5 min and to analyse the resulting solutions for the
histamine concentration.
Aqueous hislamine quality control samples. Two different
quality control samples were prepared. The first one
(sample IV) consisted only of 01 mol/1 hydrochloric acid
with no exogenous histamine. Sample V was prepared by
diluting 200 p\ of the histamine stock solution with 01
mol/1 hydrochloric acid to 100 ml to give a final
concentration of 10 nmol/l histamine. Exactly 5 ml of
both quality control samples were dispensed into 17-mI
glass ampules and sealed with butyl-rubber torches.
Methods
Design of the study. A 3-month preparatory phase (June-
August 1988) was needed to design and start the study.
Table 3. A summary of statements about accuracy and precision
of the participating laboiatories as a result of presentation in
Youdcn plots of histamine determinations in plasma and
aqueous solutions
Accuracy Precision
Plasma Aqueous Plasma Aqueous
Gas chroma lography-mass spectrometry
2 4- + +
Enzymatic single isotopic assay
3 -
Fluorometric-fluoroenzymatic assay
4 + + +
5 + - +
6 * - •
Radioimmunoassay
7 + * +
8 - + +
9 + + -I-
High performance liquid chromatography
10 - - +
11 + + + -I-
The laboratories are indicated by numbers corresponding with
Figs I and 2 and Table 2.
* Laboratories unable to produce results.
This included (1) the preparatioti of the samples and their
control for stability under field conditions (sec Materials),
(2) the preparation of standardized and clear-cul instruc-
tions and report forms, including a questionnaire about
the method used and (3) the selection of experienced
participants and current methods with agreement to
perform the analysis within 6 weeks.
Each participating laboratory was provided by mail
with (I) plasma samples I III in duplicate, (2) aqueous
samples IV and V, (3) otie solvent sample (15 ml 0-1 mol/l
hydrochloric acid, Suprapur® 30% in water; HPLC
quality. Baker) and (4) instructions and report forms. No
participant had information on the amount of histamine
in the samples. The samples were only identified as
plasma or aqueous samples.
In total, 10 European laboratories were asked to
participate in this study, two for each analytical method:
GCMS, HDIA, FFEA, RIA or HPLC.
Evaluation of the results. The results were evaluated
according to the recommendation on quality control in
clinical chemistry given by the IFCC [58]. Target values
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Plasma histamine: means of reference
values between 1970 and 1989
IUUulli
B 13 10 1& 32
n2 »-i 82 83 83
11 23 30 2J 3\
87 97 B8 BB SB 6B 89 BS V
12 27 38 37 S2 2B 3B I t R
Fig. 3. A graphical presentation of Ihe
means of reference values, reported
between 1970 and 1989 (Table 1). The
linear regression line can be described
were defined as the grand mean of all results after removal
of'outliers'. "Outliers' are discordant data,, not represen-
tative ofthe majority of results and were defined as results
lying outside the mean ± 3s.d. The imprecision and
inaccuracy of the different methods and laboratories was
calculated using Youden plots [62]. The Youden plot uses
a graphical display of two unrelated specimens of differ-
ent analyte concentration and illustrates, in a limited
fashion, the presence of imprecision and inaccuracy.
Results on specimens X and Y from each laboratory are
transformed by the relationship j:,'=(A:i —.f)/s.d.,: and
M=O'i -v)/s.d.,.. where x and y are the means of all .v and
1', respectively, and s.d.v and s.d.,, are the standard
deviations of all .x and } \ respectively (outliers excluded in
each case). Transformed pairs of values can then be
plotted. The s.d. scales on both .v and y axes arc identical,
so that a circle may be drawn with centre 0,0 (transformed
from .v.y) and radius 2s.d.. which, in theory, should
contain approximately 95% of the results. Two parallel
tangents, at 45' to both x and y axes, are drawn. Results
outside the circle show the presence of inaccuracy. Results
outside the parallel lines indicate that there is a major
component of imprecision.
According to IUPAC rules, the plasma histamine
concentration is expressed in nmol/1, although we are
aware ofthe fact that in many reports the old unit, ng/ml.
still is used. The advantage of nmol/1 is that the base can
not be mistaken with the salt. The conversion from nmol/l
into ng/ml is multiplication by 0111.
Alt participating laboratories were informed about the
results before using them for any kind of presentation.
The results of each individual participant was and will
remain strictly confidential.
Results
The difficulties that arise in a multicentre study like this,
may be illustrated by the following facts. Only two
participants reported their results within the specified
time. The participants asked to analyse their samples with
the EDIA technique were unable to run the method for
different reasons; one of them used the FFEA and the
other one the enzymatic single isotopic assay (ESIA). One
laboratory used two methods. HPLC and RIA. for the
same set of samples. For this reason we received 11 results
all together. In Table 2 the 11 analytical methods,
combined with the reference(s) as reported by the partici-
pants, are shown.
The mean histamine concentrations in the three dupli-
cate plasma samples after (1) lyophilization and 4 weeks
of storage at +4°C (Ia, b; Ila, b; Ilia, b) and (2) storage at
- 2 0 Cforafewdays(Ic .d;IIc .d;IIIc .d)were3 4. 13-8
and 53 4. and 3 3. 13-8 and 54-7 nmol/1, respectively. It
was concluded that lyophilized plasma samples were
stable enough to be used in this study.
Figure 1 shows the results ofthe participating labora-
tories after analysis of the five different samples. One
participant was unable to measure histamine in the
plasma samples reliably (no. 6: FFEA) and another one
had problems with the determination in the aqueous
samples (no. 7: RIA).
The imprecision and inaccuracy of the different meth-
ods for the measurement of histamine in plasma and
aqueous solutions are shown in Fig. 2. Figure 2a is u
Youden plot ofthe two unrelated plasma samples I and
III. These plasma samples have histamine concentrations
that might be defined as pathological (>9 nmol/l) [65].
Concerning the measurement of histamine in plasma,
laboratories 3 (ESIA), 8 (RIA) and 10 (HPLC) were
inaccurate (outside the circle) and laboratory 3 (ESIA)
was also imprecise (outside the parallel lines). Figure 2b is
a Youden plot of the two unrelated aqueous histamine
solutions. Concerning the measurement of histamine in
these samples, laboratories 3 (ESIA), 5 (FFEA), 6
(FFEA) and 10 (HPLC) were inaccurate (outside the
circle) and laboratories 3 (ESIA). 6 (FFEA) and 10
(HPLC) were also imprecise (outside the parallel lines).
The results of the Youden plots are summarized in
Table 3.
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Discussion
In this quality-control study we have attempted lo
compare five comonly used histamine assays in different
laboratories in Europe for the determination of clinically
relevant concentrations of histamine in human plasma
(0-45 nmol/l) and aqueous solutions (0-10 nmol/l). For
this purpose, lyophilized plasma samples were checked
with regard to stability and found to be suitable for use in
the present quality control study.
Unfortunately, we were unable to incorporate two
EDIAs in this study. Eventually, the two laboratories
concerned reported results obtained with other methods,
i.e. FFEA and ESIA. Nevertheless., the EDIA method is
commonly used and claims good results [29-31] (Table 1).
In contrast to Gleieh and Hull [57], who found great
variation of results obtained by different laboratories, this
study showed that 7/11 results obtained with the five
different methods were accurate, and precise in the
plasma range of histamine between 9 and 45 nmol/l (Figs
la and Ic, 2a; Table 3). The results on plasma II (Fig. Ib:
normal plasma pool without addition of external hista-
mine) confirm this observation, although in a Youden
plot making use of the results on plasma II from
laboratory 8 would just have been accurate, while
laboratory 7 would just have been inaccurate. Remark-
able in plasma II is the coefficient of variation of 96'>;>,
which is much higher than in the other two plasma
samples (III: f 7% and I: 11 -6%). However, this high value
is in accord with the variation in recently reported
reference values between 1980 and 1989 (Table 1:
CV = 67%).
Surprisingly, with respect to measuring histamine in a
simple matrix such as aqueous solutions IV and V, less
laboratories were precise and accurate (6/11) in compari-
son with the determination in plasma (7/11) (Figs Id and
le, 2b; Table 3). This may be due to the lower concentra-
tion of histamine in these samples. In correspondence
with the results on the plasma samples, the lowest
concentrations also showed the greatest variation:
CV=I2O%. Only 3/11 laboratories really reported 0
nmol/l in the blank sample IV (Fig. Id).
In general, estimating concentrations within the nor-
mal range seems to be the most difficult part of measuring
histamine in human plasma. As in many studies these
basal values are the starting point for further investiga-
tions and conclusions, this subject requires special atten-
tion.
The histamine concentration eventually measured in
plasma, while using a certain analytical method, is the
result of (1) the 'true" value of circulating plasma
histamine in the patient, (2) sample collection and plasma
preparation and (3) the analytical method.
(1) Unwanted influence may be caused by the ingestion
of histamine-rich food [66].
(2) During sample collection by venepuncture and
plasma preparation, histamine may be released from
basophilic leucocytes (mainly) and mast cells. This
may be caused by: injury, venous stasis, haemolysis,
clotting, centrifuging too fast and storage of the
blood samples, after collection, for more than 30 min
and not on ice [40,51,67]. In the past clinical studies
have been published in which serum histamine was
measured [68,69], although, because of complement
activation during blood clotting, a histamine value in
serum will inform about the number of releasability
of basophils rather than about the actual concentra-
tion of'free* histamine in blood [40].
(3) Quality-control studies like this can help to solve this
problem by evaluating the individual method.
The most recent GCMS and RIA studies suggest a
mean reference value for plasma histamine of approxi-
mately 1-3 nmol/i [40-42], which is confirmed by the
linear regression line in the graphical presentation of the
reported reference values from 1970 to 1989, as listed in
Table I (Fig. 3). As can be seen' from Table I and Fig. 3,
over the last 20-30 years the reference values have been
decreased thanks to more sophisticated methods, and are
increasingly able to prevent false interference. Also the
problems of sample taking, provoking falsely high results,
are better recognized.
Observing the individual accuracy within the five
different techniques (Table 3), it is conceivable that the
negative scores ofsome laboratories using FFFA, RIA or
HPLC were not due to unreliable methods, but due to
problems with the performances at the time of the study.
Indications for this are the accurate performances of
other laboratories with the same technique and using
more or less the same method.
This study revealed the need for further and more
extended quality-control studies. Defined reference stan-
dards, methods and laboratories for plasma histamine
measurements are now required. This seems particularly
important because various methods, also applicable to
less specialized laboratories, are now on the market or will
shortly appear.
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